Scailyte Quarterly Update December 2020
Scailyte quarterly update, highlighting that the company is among the twelve finalists in a global competition for innovative University spin-offs organized by Nature Research and Merck. Scailyte has started a collaboration with Karolinska Institutet Sweden. Here is a quote from Petter Brodin, Associate Professor of Immunology – “I am happy to join forces with Scailyte AG to use single-cell analysis and advanced analytics towards better understanding human immune-mediated diseases.” Read more below:
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
For more information, visit www.scailyte.com and connect on social media @LinkedIn and @Twitter.
ScailyteTM and ScaiVisionTM are registered trademarks proprietary to Scailyte AG.
Recent News
Machine learning meets multi-omics for precision medicine
Bringing industry and academia together to discuss the potential impact of single-cell analytics pow
Recent News
Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies
Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better
Recent News
VACANCY: Technical Lead / Product Owner for a clinical diagnostic software
Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel
Recent News
VACANCY: Data Scientist in Biomarker Discovery
Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel
Recent News
True precision medicine through single-cell science - Nature
ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m
Recent News
Scailyte AG Announces a partnership with Sirona DX
Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single
Recent News
WEBINAR: Supervised learning of disease-associated cell states and dynamics
Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit
Recent News
PODCAST: Discovering diseases with artificial intelligence
PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams
Recent News
Machine learning meets multi-omics for precision medicine
Bringing industry and academia together to discuss the potential impact of single-cell analytics pow
Understanding Resistant to CAR-T Immunotherapy to Develop Better Next-generation Therapies
Register for Scailyte's webinar on "Understanding Resistant to CAR-T Immunotherapy to Develop Better
Recent News
VACANCY: Technical Lead / Product Owner for a clinical diagnostic software
Scailyte is a globally recognised spin-off from ETH Zürich and a pioneer in the field of single-cel
VACANCY: Data Scientist in Biomarker Discovery
Scailyte is a globally recognized spin-off from ETH Zürich and a pioneer in the field of single-cel
Recent News
True precision medicine through single-cell science - Nature
ScaiVision identifies disease signatures predicting drug efficacy & drug mode of action. Precision m
Scailyte AG Announces a partnership with Sirona DX
Scailyte AG announces a strategic partnership with Sirona DX for AI-driven end-point specific single
Recent News
WEBINAR: Supervised learning of disease-associated cell states and dynamics
Watch Scailyte's webinar on "Supervised learning of disease-associated cell states and dynamics" wit
PODCAST: Discovering diseases with artificial intelligence
PODCAST: Discovering diseases with artificial intelligence. Listen to this episode of Binary Dreams